2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.

E. Savoye, M. Macher, Kidney Working Group, C. Legeai, C. Antoine.
Evaluation of Renal Function After a Transition to Everolimus or Mycophenolate Mofetil in Liver Transplant Recipients.

C. Perez,¹ J. Fleming,¹ M. Sell,¹ B. O'brien,¹ A. Rogers,¹ I. Lee,¹ C. Mardis,¹ A. Mardis,¹ N. Patel,¹ H. Meadows,¹ N. Pilch,² K. Chavin,² D. Dubay,² R. Vinayak,² D. Taber.²
Evaluation of the Conversion from Brand Name to Generic Immunosuppression in Hospitalized Organ Transplant Recipients.

L. DeZotell,¹ K. Blunck,¹ J. Guy,¹ M. Woods,¹ M. Reffett,² J. Terrell,² A. Palermo,² K. Gosch,³ L. Cummings.⁴
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.

A. Khalil, S. Ganesh, C. Hughes, A. Tevar, J. Hatche, S. Esper, A. Humar.
Evaluation of Vancomycin Resistant Enterococcus (VRE) Colonization and Infection Rate in Adult Liver Transplant Patients.

E. Aldag,¹ G. Fouth,¹ R. Pedersen,¹ L. Fehrenbacher,^1,2 A. Sahajpal,¹ V. Gunabushanam,¹ D. Kramer.¹
Even Non-Donor-Specific HLA-Antibodies Are Associated with a Progressive Decline in Kidney Transplant Function.

T. Mueller, K. Gerritsen, R. van Breemen, B. Ruesi, S. von Moos, P. Cippa.
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value.

D. Stewart,¹ A. Kucheryavaya,¹ D. Tyan,² H. Gebel,³ R. Bray,³ N. Turgeon.³
Everolimus Does Not Increase Risk of Delayed Graft Function or Prolong Duration of Dialysis in Renal Transplantation.

F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
Everolimus Is Associated with Less Weight Gain Than Tacrolimus Two Years Following Liver Transplantation: Results of a Randomized Multicenter Study.

M. Charlton,¹ M. Rinella,² D. Patel,³ K. McCague,³ J. Heimbach,⁴ K. Watt.⁴
Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.

P. Garcia, H. Takase, H. Nga, M. Contti, J. Hueb, L. Morales-Buenrostro.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z